Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DECKERS OUTDOOR CORPDECK · Entity 848 | Director | September 01, 2026 | September 02, 2026 |
| GCT Semiconductor Holding, Inc.GCTS · Entity 6473 | Director · Class I Director | September 30, 2026 | October 02, 2026 |
| SOCKET MOBILE, INC.sckt · Entity 8279 | Director | May 22, 2019 | May 24, 2019 |
| SYNAPTICS IncSYNA · Entity 4089 | Director | November 03, 2025 | November 04, 2025 |
| Twist Bioscience CorpTWST · Entity 3619 | Director | February 05, 2026 | February 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DECKERS OUTDOOR CORP
Report date September 01, 2026 · Filed September 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 63,846 |
Reported balance
After 2026-09-01 transaction · row 1
1 source rowRow 1 · 2026-09-01 · Grant · Acquired 535 · Balance 63,846 F1: Quarterly shares issued pursuant to the Compensation Plan for the Company's Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Quarterly shares issued pursuant to the Compensation Plan for the Company's Board of Directors.
GCT Semiconductor Holding, Inc.
Report date September 30, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 147,872 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 12,971 · Balance 147,872 F1: Represents Restricted Stock Units ("RSUs") acquired pursuant to the terms of the GCT Semiconductor Holding, Inc. (the "Issuer") GCT 2024 Omnibus Incentive Compensation Plan. Each RSU represents the right to receive one share of common stock, par value $0.0001 per share ("Common Stock") of the Issuer following vesting. F2: The number of shares subject to and issuable under the award is determined on the last day of each calendar quarter during the period April 1, 2026 through March 31, 2027 (beginning with the quarter ending June 30, 2026) by dividing $27,500 by the fair market value per share of Common Stock, which was determined to be $2.12 on September 30, 2026, rounded down to the nearest whole share. F3: The RSUs will vest on March 31, 2027, subject to continued service through such date. F4: No expiration date is applicable to restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Restricted Stock Units ("RSUs") acquired pursuant to the terms of the GCT Semiconductor Holding, Inc. (the "Issuer") GCT 2024 Omnibus Incentive Compensation Plan. Each RSU represents the right to receive one share of common stock, par value $0.0001 per share ("Common Stock") of the Issuer following vesting.
F2: The number of shares subject to and issuable under the award is determined on the last day of each calendar quarter during the period April 1, 2026 through March 31, 2027 (beginning with the quarter ending June 30, 2026) by dividing $27,500 by the fair market value per share of Common Stock, which was determined to be $2.12 on September 30, 2026, rounded down to the nearest whole share.
F3: The RSUs will vest on March 31, 2027, subject to continued service through such date.
F4: No expiration date is applicable to restricted stock units.
SOCKET MOBILE, INC.
Report date May 22, 2019 · Filed May 24, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock optionSEC Table II · derivative / convertible security · Conversion / exercise price $2.45 · Expires 2029-05-22 | Direct | 31,000 |
Reported balance
After 2019-05-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-05-22 · Grant · Acquired 8,000 · Balance 31,000 F1: Vests monthly over a 24 months period commencing May 22, 2019 |
Filing footnotes · ownership attribution and instrument terms
F1: Vests monthly over a 24 months period commencing May 22, 2019
SYNAPTICS Inc
Report date November 03, 2025 · Filed November 04, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 45,719 |
Reported balance
After 2025-11-03 transaction · row 1
1 source rowRow 1 · 2025-11-03 · Grant · Acquired 3,036 · Balance 45,719 F1: One-fourth of the total number of restricted stock units shall vest each quarter until fully vested on November 3, 2026, or for a Director not standing for re-election, the date of the Issuer's 2026 Annual Meeting of Stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: One-fourth of the total number of restricted stock units shall vest each quarter until fully vested on November 3, 2026, or for a Director not standing for re-election, the date of the Issuer's 2026 Annual Meeting of Stockholders.
Twist Bioscience Corp
Report date February 05, 2026 · Filed February 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 33,251 |
Reported balance
After 2026-02-05 transaction · row 1
1 source rowRow 1 · 2026-02-05 · Grant · Acquired 5,095 · Balance 33,251 F1: 100% of the Shares subject to the Annual Equity Award will vest upon the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the first annual meeting of stockholders following the date of grant, provided that the Non-Employee Director is a Service Provider on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: 100% of the Shares subject to the Annual Equity Award will vest upon the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the first annual meeting of stockholders following the date of grant, provided that the Non-Employee Director is a Service Provider on each vesting date.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ADESTO TECHNOLOGIES Corp
Report date June 29, 2020 · Filed July 02, 2020
Section 16 reporting ended · disclosed 2020-07-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-06-29 transaction · row 1
1 source rowRow 1 · 2020-06-29 · Other · Disposed 45,412 · Balance 0 F1: On February 20, 2020, Adesto Technologies Corporation (the "Company") entered into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the "Merger Agreement") with Dialog Semiconductor plc ("Dialog") and Azara Acquisition Corp., a wholly-owned direct or indirect subsidiary of Dialog ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned direct or indirect subsidiary of Dialog. Pursuant to the Merger Agreement all shares of Company common stock outstanding immediately prior to the effective time of the Merger (the "Effective Time"), were canceled and converted automatically into the right to receive $12.55 in cash. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.30 · Expires 2025-04-28 | Direct | 0 |
Reported balance
After 2020-06-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-06-29 · Disposition to issuer · Disposed 7,575 · Balance 0 F2: Pursuant to the Merger Agreement, at the Effective Time, each Company stock option was cancelled and converted into the right to receive an amount in cash equal to (i) the difference between $12.55 and the exercise price of such stock option multiplied by (ii) the number of shares subject to such stock option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.65 · Expires 2020-12-13 | Direct | 0 |
Reported balance
After 2020-06-29 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-06-29 · Disposition to issuer · Disposed 17,160 · Balance 0 F2: Pursuant to the Merger Agreement, at the Effective Time, each Company stock option was cancelled and converted into the right to receive an amount in cash equal to (i) the difference between $12.55 and the exercise price of such stock option multiplied by (ii) the number of shares subject to such stock option. |
Filing footnotes · ownership attribution and instrument terms
F1: On February 20, 2020, Adesto Technologies Corporation (the "Company") entered into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the "Merger Agreement") with Dialog Semiconductor plc ("Dialog") and Azara Acquisition Corp., a wholly-owned direct or indirect subsidiary of Dialog ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned direct or indirect subsidiary of Dialog. Pursuant to the Merger Agreement all shares of Company common stock outstanding immediately prior to the effective time of the Merger (the "Effective Time"), were canceled and converted automatically into the right to receive $12.55 in cash.
F2: Pursuant to the Merger Agreement, at the Effective Time, each Company stock option was cancelled and converted into the right to receive an amount in cash equal to (i) the difference between $12.55 and the exercise price of such stock option multiplied by (ii) the number of shares subject to such stock option.
OUTERWALL INC
Report date September 23, 2016 · Filed September 27, 2016
Section 16 reporting ended · disclosed 2016-09-27. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2016-09-27 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2016-09-23 · Other · Disposed 8,690 · Balance 3,783 F1: Pursuant to the terms of the Agreement and Plan of Merger, dated July 24, 2016, by and among Outerwall Inc. ("Issuer"), Aspen Parent, Inc., Aspen Merger Sub, Inc., Redwood Merger Sub, Inc. and Redbox Automated Retail, LLC (the "Merger Agreement"), on August 5, 2016, Aspen Merger Sub, Inc. made an offer (the "Offer") to purchase each outstanding share of the Issuer's common stock for $52.00 per share, in cash, without interest (the "Merger Consideration"). The shares shown on this line were tendered in the Offer. F2: Pursuant the Merger Agreement, each outstanding share of common stock of Issuer at the Effective Time (as defined in the Merger Agreement) was converted into the right to receive the Merger Consideration. Row 2 · 2016-09-27 · Other · Disposed 3,783 · Balance 0 F2: Pursuant the Merger Agreement, each outstanding share of common stock of Issuer at the Effective Time (as defined in the Merger Agreement) was converted into the right to receive the Merger Consideration. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $56.48 · Expires 2021-07-05 | Direct | 0 |
Reported balance
After 2016-09-27 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2016-09-27 · Other · Disposed 1,272 · Balance 0 F3: Pursuant to the Merger Agreement, each option to purchase shares of common stock of the Issuer, whether vested or unvested, was, as of the Effective Time, canceled and converted into the right to receive a payment equal to the product of (i) the number of shares of common stock subject to such option immediately before the Effective Time and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such option. F4: This option is fully vested and exercisable. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $59.08 · Expires 2023-06-27 | Direct | 0 |
Reported balance
After 2016-09-27 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2016-09-27 · Other · Disposed 1,826 · Balance 0 F3: Pursuant to the Merger Agreement, each option to purchase shares of common stock of the Issuer, whether vested or unvested, was, as of the Effective Time, canceled and converted into the right to receive a payment equal to the product of (i) the number of shares of common stock subject to such option immediately before the Effective Time and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such option. F4: This option is fully vested and exercisable. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $61.01 · Expires 2022-06-07 | Direct | 0 |
Reported balance
After 2016-09-27 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2016-09-27 · Other · Disposed 1,226 · Balance 0 F3: Pursuant to the Merger Agreement, each option to purchase shares of common stock of the Issuer, whether vested or unvested, was, as of the Effective Time, canceled and converted into the right to receive a payment equal to the product of (i) the number of shares of common stock subject to such option immediately before the Effective Time and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such option. F4: This option is fully vested and exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of the Agreement and Plan of Merger, dated July 24, 2016, by and among Outerwall Inc. ("Issuer"), Aspen Parent, Inc., Aspen Merger Sub, Inc., Redwood Merger Sub, Inc. and Redbox Automated Retail, LLC (the "Merger Agreement"), on August 5, 2016, Aspen Merger Sub, Inc. made an offer (the "Offer") to purchase each outstanding share of the Issuer's common stock for $52.00 per share, in cash, without interest (the "Merger Consideration"). The shares shown on this line were tendered in the Offer.
F2: Pursuant the Merger Agreement, each outstanding share of common stock of Issuer at the Effective Time (as defined in the Merger Agreement) was converted into the right to receive the Merger Consideration.
F3: Pursuant to the Merger Agreement, each option to purchase shares of common stock of the Issuer, whether vested or unvested, was, as of the Effective Time, canceled and converted into the right to receive a payment equal to the product of (i) the number of shares of common stock subject to such option immediately before the Effective Time and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such option.
F4: This option is fully vested and exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 08, 2021 Filed Feb 10, 2021 17:25 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 2,400 | $120.18 | $288,427.20 |
DisclosureSEC source: 0001209191-21-009164 · doc4.xml · nonDerivative · entry 3 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,512 Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 17:25 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 2,302 | $89.29 | $205,545.58 |
DisclosureSEC source: 0001209191-21-009164 · doc4.xml · nonDerivative · entry 2 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,912 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 17:25 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 2,400 | $62.11 | $149,052.00 |
DisclosureSEC source: 0001209191-21-009164 · doc4.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2021 Filed Feb 6, 2021 01:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantDirector Stock Option (right to buy) · Derivative | 973 | $0.00 Strike: $189.96 | $0.00 |
DisclosureSEC source: 0001214659-21-001427 · marketforms-51429.xml · derivative · entry 2 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 973 Underlying: Common Stock · 973 shares Expires 2031-02-02 F2 · derivative.exercise_date: 100% of the shares subject to the option will vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 03, 2021 Filed Feb 6, 2021 01:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 486 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-21-001427 · marketforms-51429.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,200 F1 · shares: Represents a restricted stock unit award (the "RSU Award") of which 100% vests on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 19:11 UTC | DECKERS OUTDOOR CORP DECK · Entity 848 | GrantCommon Stock | 108 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-002372 · primary_01.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,685 F1 · shares: Quarterly shares issued pursuant to the Compensation Plan for the Company's Board of Directors. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 17:26 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 2,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-056842 · doc4.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,210 F1 · shares: 25% of the total number of deferred stock units shall vest each quarter until fully vested on October 31, 2021, or for a Director not standing for re-election, the date of the Issuer's 2021 Annual Meeting of Stockholders. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 23:24 UTC | DECKERS OUTDOOR CORP DECK · Entity 848 | GrantCommon Stock | 153 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-001887 · primary_01.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,577 F1 · shares: Quarterly shares issued pursuant to the Compensation Plan for the Company's Board of Directors. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:29 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 4,500 | $0.00 Strike: $46.50 | $0.00 |
DisclosureSEC source: 0001209191-20-046419 · doc4.xml · derivative · entry 6 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,500 shares Expires 2020-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable on the 28th day of each month following the October 28, 2013 date of grant, until fully vested on October 28, 2014. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:29 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 419 | $88.99 | $37,286.81 |
DisclosureSEC source: 0001209191-20-046419 · doc4.xml · nonDerivative · entry 5 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,743 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated May 29,2020. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:29 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 1,850 | $87.87 | $162,553.03 |
DisclosureSEC source: 0001209191-20-046419 · doc4.xml · nonDerivative · entry 4 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,162 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated May 29,2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.55 to $87.96, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:29 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 8,013 | $86.12 | $690,092.38 |
DisclosureSEC source: 0001209191-20-046419 · doc4.xml · nonDerivative · entry 3 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,012 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated May 29,2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.82 to $86.71, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:29 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 18,968 | $85.46 | $1,620,982.52 |
DisclosureSEC source: 0001209191-20-046419 · doc4.xml · nonDerivative · entry 2 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,025 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated May 29,2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.81 to $85.80, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:29 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 4,500 | $46.50 | $209,250.00 |
DisclosureSEC source: 0001209191-20-046419 · doc4.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 22:06 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 1,805 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-006855 · marketforms-49419.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,714 F1 · shares: Represents a restricted stock unit award ("RSU") of which 241 RSUs vest on each quarterly anniversary after August 10, 2019 and the final 93 RSUs vest on November 10, 2021, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| June 29, 2020 Filed Jul 2, 2020 01:03 UTC | ADESTO TECHNOLOGIES Corp IOTS · Entity 12356 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 17,160 | Not disclosed Strike: $1.65 | Not disclosed |
DisclosureSEC source: 0001209191-20-039965 · doc4.xml · derivative · entry 3 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,160 shares Expires 2020-12-13 F2 · price: Pursuant to the Merger Agreement, at the Effective Time, each Company stock option was cancelled and converted into the right to receive an amount in cash equal to (i) the difference between $12.55 and the exercise price of such stock option multiplied by (ii) the number of shares subject to such stock option. F2 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each Company stock option was cancelled and converted into the right to receive an amount in cash equal to (i) the difference between $12.55 and the exercise price of such stock option multiplied by (ii) the number of shares subject to such stock option. Read SEC document |
| June 29, 2020 Filed Jul 2, 2020 01:03 UTC | ADESTO TECHNOLOGIES Corp IOTS · Entity 12356 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 7,575 | Not disclosed Strike: $3.30 | Not disclosed |
DisclosureSEC source: 0001209191-20-039965 · doc4.xml · derivative · entry 2 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,575 shares Expires 2025-04-28 F2 · price: Pursuant to the Merger Agreement, at the Effective Time, each Company stock option was cancelled and converted into the right to receive an amount in cash equal to (i) the difference between $12.55 and the exercise price of such stock option multiplied by (ii) the number of shares subject to such stock option. F2 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each Company stock option was cancelled and converted into the right to receive an amount in cash equal to (i) the difference between $12.55 and the exercise price of such stock option multiplied by (ii) the number of shares subject to such stock option. Read SEC document |
| June 29, 2020 Filed Jul 2, 2020 01:03 UTC | ADESTO TECHNOLOGIES Corp IOTS · Entity 12356 | OtherCommon Stock | 45,412 | $12.55 | $569,920.60 |
DisclosureSEC source: 0001209191-20-039965 · doc4.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On February 20, 2020, Adesto Technologies Corporation (the "Company") entered into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the "Merger Agreement") with Dialog Semiconductor plc ("Dialog") and Azara Acquisition Corp., a wholly-owned direct or indirect subsidiary of Dialog ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned direct or indirect subsidiary of Dialog. Pursuant to the Merger Agreement all shares of Company common stock outstanding immediately prior to the effective time of the Merger (the "Effective Time"), were canceled and converted automatically into the right to receive $12.55 in cash. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 00:45 UTC | DECKERS OUTDOOR CORP DECK · Entity 848 | GrantCommon Stock | 156 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-001488 · primary_01.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,424 F1 · shares: Quarterly shares issued pursuant to the Compensation Plan for the Company's Board of Directors. Read SEC document |
| April 24, 2020 Filed Apr 27, 2020 21:25 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionDirector Stock Option (Right To Buy) · Derivative | 18,750 | $0.00 Strike: $31.76 | $0.00 |
DisclosureSEC source: 0001209191-20-025853 · doc4.xml · derivative · entry 2 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,750 shares Expires 2020-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of the total number of shares subject to the option vested and became exercisable on the twelve month anniversary of the April 27, 2010 vesting commencement date, and 1/48th of the total number of shares subject to the option vested and became exercisable on the 27th day of each month thereafter. Read SEC document |
| April 24, 2020 Filed Apr 27, 2020 21:25 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 18,750 | $31.76 | $595,500.00 |
DisclosureSEC source: 0001209191-20-025853 · doc4.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,493 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 22:53 UTC | DECKERS OUTDOOR CORP DECK · Entity 848 | GrantCommon Stock | 201 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-000839 · primary_01.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,268 F1 · shares: Quarterly shares issued pursuant to the Compensation Plan for the Company's Board of Directors. Read SEC document |
| February 04, 2020 Filed Feb 7, 2020 02:23 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantDirector Stock Option (right to buy) · Derivative | 5,648 | $0.00 Strike: $26.20 | $0.00 |
DisclosureSEC source: 0001214659-20-001011 · marketforms-47699.xml · derivative · entry 2 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,648 Underlying: Common Stock · 5,648 shares Expires 2030-02-03 F2 · derivative.exercise_date: 100% of the shares subject to the option will vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 04, 2020 Filed Feb 7, 2020 02:23 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 1,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-001011 · marketforms-47699.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,909 F1 · shares: Represents a restricted stock unit award (the "RSU Award") of which 100% vests on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 04, 2020 Filed Mar 5, 2021 21:40 UTC Amendment | Twist Bioscience Corp TWST · Entity 3619 | GrantDirector Stock Option (right to buy) · Derivative | 11,297 | $0.00 Strike: $26.20 | $0.00 |
DisclosureSEC source: 0001214659-21-002793 · marketforms-51435.xml · derivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,297 Underlying: Common Stock · 11,297 shares Expires 2030-02-03 F1 · shares: The Form 4 originally filed on February 6,2020 incorrectly reported 5,648 options. F2 · derivative.exercise_date: 100% of the shares subject to the option will vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date. F1 · derivative.underlying_shares: The Form 4 originally filed on February 6,2020 incorrectly reported 5,648 options. F1 · balance_after: The Form 4 originally filed on February 6,2020 incorrectly reported 5,648 options. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 23:04 UTC | DECKERS OUTDOOR CORP DECK · Entity 848 | GrantCommon Stock | 193 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-19-002338 · primary_01.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,067 F1 · shares: Quarterly shares issued pursuant to the Compensation Plan for the Company's Board of Directors. Read SEC document |
| October 31, 2019 Filed Nov 5, 2019 02:58 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 4,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-055060 · doc4.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,743 F1 · shares: 25% of the total number of deferred stock units shall vest each quarter until fully vested on October 31, 2020, or for a Director not standing for re-election, the date of the Issuer's 2020 Annual Meeting of Stockholders Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 22:30 UTC | DECKERS OUTDOOR CORP DECK · Entity 848 | GrantCommon Stock | 208 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-19-001899 · primary_01.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,874 F1 · shares: Quarterly shares issued pursuant to the Compensation Plan for the Company's Board of Directors. Read SEC document |
| August 12, 2019 Filed Aug 14, 2019 21:45 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $23.16 | $0.00 |
DisclosureSEC source: 0001209191-19-045978 · doc4.xml · derivative · entry 3 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2019-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable on the 29th day of each month following the October 31, 2012 date of the grant. Read SEC document |
| August 12, 2019 Filed Aug 14, 2019 21:45 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 6,000 | $33.25 | $199,500.00 |
DisclosureSEC source: 0001209191-19-045978 · doc4.xml · nonDerivative · entry 2 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,449 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated May 16, 2019. Read SEC document |
| August 12, 2019 Filed Aug 14, 2019 21:45 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 6,000 | $23.16 | $138,960.00 |
DisclosureSEC source: 0001209191-19-045978 · doc4.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,449 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 21, 2019 Filed Aug 29, 2019 22:24 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantDirector Stock Option (right to buy) · Derivative | 3,093 | $0.00 Strike: $30.08 | $0.00 |
DisclosureSEC source: 0001209191-19-047751 · doc4.xml · derivative · entry 3 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,093 Underlying: Common Stock · 3,093 shares Expires 2029-06-20 F3 · derivative.exercise_date: The stock option has fully vested and is immediately exercisable. Read SEC document |
| June 21, 2019 Filed Aug 29, 2019 22:24 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 1,497 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-047751 · doc4.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,497 F1 · shares: Represents a restricted stock unit award that has fully vested. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 20:34 UTC | DECKERS OUTDOOR CORP DECK · Entity 848 | GrantCommon Stock | 189 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-19-001461 · primary_01.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,666 F1 · shares: Quarterly shares issued pursuant to the Compensation Plan for the Company's Board of Directors. Read SEC document |
| June 04, 2019 Filed Jun 6, 2019 22:26 UTC | ADESTO TECHNOLOGIES Corp IOTS · Entity 12356 | GrantCommon Stock | 7,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-012980 · doc1.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,412 F1 · shares: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. 100% of the RSUs will vest on June 4, 2020. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting. Read SEC document |
| May 22, 2019 Filed May 24, 2019 18:24 UTC | SOCKET MOBILE, INC. sckt · Entity 8279 | GrantCommon stock option · Derivative | 8,000 | $0.00 Strike: $2.45 | $0.00 |
DisclosureSEC source: 0000944075-19-000020 · primary_doc.xml · derivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,000 Underlying: Common · 8,000 shares Expires 2029-05-22 F1 · derivative.exercise_date: Vests monthly over a 24 months period commencing May 22, 2019 Read SEC document |
| May 20, 2019 Filed Aug 29, 2019 22:24 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantDirector Stock Option (right to buy) · Derivative | 13,444 | $0.00 Strike: $25.29 | $0.00 |
DisclosureSEC source: 0001209191-19-047751 · doc4.xml · derivative · entry 2 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,444 Underlying: Common Stock · 13,444 shares Expires 2029-05-19 F2 · derivative.exercise_date: 1/3rd of the shares subject to the option will vest and become exercisable on May 20, 2020 and each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| May 20, 2019 Filed Mar 5, 2021 21:30 UTC Amendment | Twist Bioscience Corp TWST · Entity 3619 | GrantDirector Stock Option (right to buy) · Derivative | 23,033 | $0.00 Strike: $25.29 | $0.00 |
DisclosureSEC source: 0001214659-21-002781 · marketforms-51611.xml · derivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,033 Underlying: Common Stock · 23,033 shares Expires 2029-05-19 F1 · shares: The Form 4 originally filed on August 29, 2019 incorrectly reported 13,444 options. F2 · derivative.exercise_date: 1/3rd of the shares subject to the option will vest and become exercisable on May 20, 2020 and each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. F1 · derivative.underlying_shares: The Form 4 originally filed on August 29, 2019 incorrectly reported 13,444 options. F1 · balance_after: The Form 4 originally filed on August 29, 2019 incorrectly reported 13,444 options. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 21:43 UTC | DECKERS OUTDOOR CORP DECK · Entity 848 | GrantCommon Stock | 219 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-19-000810 · primary_01.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,477 F1 · shares: Quarterly shares issued pursuant to the Compensation Plan for the Company's Board of Directors. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 23:23 UTC | DECKERS OUTDOOR CORP DECK · Entity 848 | GrantCommon Stock | 249 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-18-001613 · primary_01.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,258 F1 · shares: Quarterly shares issued pursuant to the Compensation Plan for the Company's Board of Directors. Read SEC document |
| November 13, 2018 Filed Nov 15, 2018 23:33 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 5,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-058806 · doc4.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,449 F1 · shares: 25% of the total number of deferred stock units shall vest and be delivered on January 31, 2019, April 30, 2019, July 31, 2019, and October 31, 2019. Read SEC document |
| September 25, 2018 Filed Sep 27, 2018 21:57 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $32.53 | $0.00 |
DisclosureSEC source: 0001209191-18-052484 · doc4.xml · derivative · entry 2 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2018-10-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable on the 24th day of each month following the 10/24/2011 date of grant, until fully vested on October 24, 2012. Read SEC document |
| September 25, 2018 Filed Sep 27, 2018 21:57 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 6,000 | $32.53 | $195,180.00 |
DisclosureSEC source: 0001209191-18-052484 · doc4.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,231 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2018 Filed Sep 20, 2018 00:20 UTC | DECKERS OUTDOOR CORP DECK · Entity 848 | GrantCommon Stock | 266 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-18-001230 · primary_01.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,009 F1 · shares: Quarterly shares issued pursuant to the Compensation Plan for the Company's Board of Directors. Read SEC document |
| June 19, 2018 Filed Jul 31, 2018 18:04 UTC | ADESTO TECHNOLOGIES Corp IOTS · Entity 12356 | GrantCommon Stock | 3,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-034499 · form4.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,750 F1 · shares: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no considerations. 100% of the RSUs will vest on June 19, 2019. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 23:46 UTC | DECKERS OUTDOOR CORP DECK · Entity 848 | GrantCommon Stock | 261 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-18-000930 · primary_01.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,743 F1 · shares: Quarterly shares issued pursuant to the Compensation Plan for the Company's Board of Directors. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 18:04 UTC | SOCKET MOBILE, INC. SCKT · Entity 8279 | GrantCommon stock option · Derivative | 8,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0000944075-18-000024 · primary_doc.xml · derivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 Underlying: Common · 8,000 shares Expires 2028-06-01 F1 · derivative.exercise_date: Vests monthly over a 24 month period commencing May 16, 2018. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 21:50 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $28.11 | $0.00 |
DisclosureSEC source: 0001209191-18-023855 · doc4.xml · derivative · entry 3 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2018-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/6th of the total number of shares subject to the option vested and became exercisable on the 26th day of each month following the April 26, 2011 date of grant. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 21:50 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 3,000 | $45.17 | $135,510.00 |
DisclosureSEC source: 0001209191-18-023855 · doc4.xml · nonDerivative · entry 2 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,231 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated November 17, 2017. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 21:50 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 3,000 | $28.11 | $84,330.00 |
DisclosureSEC source: 0001209191-18-023855 · doc4.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,231 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.